Related Experiment Video

Updated: Aug 5, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

Multidrug resistance: a role for cholesterol efflux pathways?

M Liscovitch1, Y Lavie

  • 1Dept of Biological Regulation, Weizmann Institute of Science, 76100, Rehovot, Israel. moti.liscovitch@weizmann.ac.il

Trends in Biochemical Sciences
|November 21, 2000
PubMed

Insights

Multidrug resistance (MDR) in cancer cells involves increased caveolin and caveolae, potentially aiding drug export. This adaptation alters cholesterol homeostasis and reduces cancer cell transformation features.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Multidrug resistance (MDR) significantly reduces chemotherapy effectiveness in cancer treatment.
  • While drug efflux transporters are known, other cellular adaptations are crucial for MDR.
  • Increased cell surface caveolae and caveolin expression are observed in MDR cancer cells.

Purpose of the Study:

  • To investigate the role of caveolin and caveolae in multidrug resistance.
  • To explore the connection between caveolin-dependent cholesterol efflux and drug transport in MDR cells.
  • To understand how caveolin upregulation impacts the phenotype and cholesterol homeostasis of MDR cancer cells.

Main Methods:

  • Analysis of caveolae and caveolin expression in multidrug-resistant cancer cells.
  • Investigation of cholesterol efflux pathways in relation to MDR.
  • Assessment of phenotypic changes and cholesterol homeostasis in MDR cells with altered caveolin levels.

Main Results:

  • Multidrug-resistant cancer cells exhibit dramatically increased cell surface caveolae and caveolin expression.
  • Upregulation of caveolin correlates with enhanced caveolin-dependent cholesterol efflux pathways.
  • These pathways may facilitate intracellular drug transport to the plasma membrane for extrusion by efflux ATPases.
  • Caveolin upregulation leads to altered cholesterol homeostasis and a loss of transformed cell phenotype in MDR cells.

Conclusions:

  • Caveolin and caveolae play a significant role in the development of multidrug resistance in cancer.
  • Caveolin-mediated cholesterol transport pathways are implicated in the mechanism of drug extrusion.
  • Targeting caveolin or associated pathways may offer novel strategies to overcome MDR and re-sensitize cancer cells to chemotherapy.

More Related Videos

Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Related Concept Videos

Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...